Search AMIA.org

Artificial intelligence (AI) adoption in global health informatics is accelerating, yet scaling, sustainability, equity, and environmental challenges limit impact, particularly in Low and Middle Income Countries (LMICs).

Modern biomedical data ecosystems increasingly rely on global cloud platforms to coordinate access to large-scale genomic and clinical datasets. However, operational governance remains largely investigator-centric, shifting the responsibility for complex security, compliance, and infrastructure management to individual laboratories. As data volumes and regulatory requirements expand, this approach fails to scale across the research enterprise. This disjointed approach creates a substantial governance burden and can slow down scientific progress. In centralized [...]

To examine the characteristics, scope, and thematic content of institutional and program-level academic artificial intelligence (AI) policies and guidance documents used by CAHIIM-accredited Health Informatics (HI) and Health Information Management (HIM) master's programs in the United States.

Clinical AI systems and models increasingly need traceable documentation that makes intended use, performance evidence, transparency, and lifecycle status explicit, yet existing model cards, datasheets, reporting guidelines, and other documentation approaches do not consistently bring together structured clinical fields, vocabulary-linked cohort descriptions, structured performance reporting, and governed documentation history. We introduce Structured, Meaningful, Auditable, Responsible, and Transparent (SMART), a framework that adapts the model card concept into structured, lifecycle-aware documentation [...]

Accurate citation of relevant publications is essential for scientific integrity in biomedical research. Large language models (LLMs) excel at text generation but often hallucinate fabricated or inaccurate citations. Retrieval-augmented generation (RAG) can mitigate these errors, yet current approaches lack semantic precision in evidence retrieval. This study aims to develop a domain-specific RAG system for reliable, context-specific biomedical citation recommendations.

Information extraction (IE) from clinical texts has advanced rapidly with recent advances in natural language processing, particularly the advent of large language models (LLMs). However, inconsistent and incomplete reporting of methodologies limits reproducibility, comparability, and clinical translation. We aimed to develop a consensus-based reporting guideline tailored to clinical IE studies.

Large-scale propensity score (LSPS) models are increasingly used to control confounding in observational studies, but their reliability in small-sample settings is unclear. Small samples can limit a study's ability to estimate propensity scores accurately and achieve adequate covariate balance, raising concerns about insufficient confounding adjustment. Resulting in small datasets being excluded, despite potentially containing valid information.

Systematic clinical phenotyping using Human Phenotype Ontology (HPO) is central to rare disease diagnosis. However, current disease prioritization (ranking candidate diseases from HPO for a patient) methods face key challenges: they often fail to account for the hierarchical structure of HPO terms, ignore dependencies among correlated terms, and do not adjust for batch effects arising from systematic differences in phenotype documentation across cohorts, institutions, or clinicians. We aim to develop [...]

Machine-learning-based clinical risk prediction models are increasingly used to support decision-making in healthcare. While class-imbalance correction techniques are commonly applied to address rare outcomes, their impact on probabilistic calibration remains insufficiently understood. This study evaluated the effect of widely used resampling strategies on both discrimination and calibration across real-world clinical prediction tasks.